RELIEFBAND NST DEVICE MODELS WB-2,WB-6,WB-R

K983907 · Woodside Biomedical, Inc. · GZJ · Dec 9, 1999 · Neurology

Device Facts

• Record ID: K983907
• Device Name: RELIEFBAND NST DEVICE MODELS WB-2,WB-6,WB-R
• Applicant: Woodside Biomedical, Inc.
• Product Code: GZJ · Neurology
• Decision Date: Dec 9, 1999
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 882.5890
• Device Class: Class 2
• Attributes: Therapeutic

Intended Use

The ReliefBand® NST™ Device is indicated for use in the treatment of nausea and vomiting (NV) due to chemotherapy, motion sickness, and pregnancy. The ReliefBand® NST™ Device is indicated as an adjunct to antiemetics in reducing postoperative nausea (PON).

Device Story

ReliefBand® NST™ is a wearable neuromodulation device; applies electrical stimulation to the median nerve at the wrist. Device operates via transcutaneous electrical nerve stimulation (TENS) principle; intended to treat nausea and vomiting associated with chemotherapy, motion sickness, and pregnancy; also serves as an adjunct to antiemetics for postoperative nausea. Operated by the patient; worn on the wrist. Output consists of controlled electrical pulses; mechanism involves nerve stimulation to modulate nausea-related pathways. Benefits include non-pharmacological symptom relief.

Clinical Evidence

No clinical data provided in the document; substantial equivalence determination based on regulatory review of the 510(k) submission.

Technological Characteristics

Wearable neuromodulation device; utilizes transcutaneous electrical nerve stimulation (TENS) to deliver electrical pulses to the median nerve. Battery-powered; wrist-worn form factor.

Indications for Use

Indicated for patients experiencing nausea and vomiting due to chemotherapy, motion sickness, or pregnancy. Also indicated as an adjunct to antiemetics for reducing postoperative nausea.

Regulatory Classification

Identification

A transcutaneous electrical nerve stimulator for pain relief is a device used to apply an electrical current to electrodes on a patient's skin to treat pain.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a stylized eagle or bird-like symbol with three curved lines representing its wings or feathers. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular fashion around the symbol.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

DEC - 9 1999

Ms. Carol. L. Patterson Consultant for Woodside Biomedical, Inc. Woodside Biomedical, Inc. 21911 Erie Lane Lake Forest, California 92630

Re: K983907 Trade Name: Relief Band® NST™ Device Regulatory Class: II Product Codes: GZJ and BWK Dated: September 9, 1999 Received: September 10, 1999

Dear Ms. Patterson:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (OS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic (QS) inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{1}------------------------------------------------

## Page 2 - Ms. Carol L. Patterson

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone] or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

pcoollfo

James E. Dillard III Acting Director Division of General and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

## INDICATIONS FOR USE

K983907 510(k) Number:

ReliefBand® NST™ Device Models WB-2, WB-6, and Device Name: WB-R

The ReliefBand® NST™ Device is indicated for use in the Indications For Use: treatment of nausea and vomiting (NV) due to chemotherapy, motion sickness, and pregnancy. The ReliefBand® NST™ Device is indicated as an adjunct to antiemetics in reducing postoperative nausea (PON).

PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

| (Division Sign-Off) | |
|-----------------------------------------|---------|
| Division of General Restorative Devices | |
| 510(k) Number | K983907 |

| Prescription Use (Per 21 CFR 801.109) | X |
|---------------------------------------|----------------------|
| | OR |
| | Over-The-Counter Use |